Medpace Holdings (MEDP) net assets (shareholders' equity)

Net assets · fiscal 2025
$459.07M

Medpace Holdings (MEDP) had net assets of $459.07M at the end of fiscal 2025 (December 31, 2025). That is 44.4% lower than the $825.55M of fiscal 2024. Figures as of 19 Nov 2026, 02:04 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Net assets, fiscal 2025
$459.07M
Change on fiscal 2024
−44.4%
Growth, 5 years
−10.6% a year
Growth, 10 years
+1.1% a year
Highest on record
$952.93Mfiscal 2021
Lowest on record
$386.39Mfiscal 2022
Fiscal years on record
112015–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Medpace Holdings net assets (shareholders' equity), in more detail

Over the five fiscal years to 2025 net assets shrank at a compound 10.6% a year; over ten years the rate was 1.1% a year. Across the 11 fiscal years on record (2015–2025), the highest was $952.93M in fiscal 2021 and the lowest $386.39M in fiscal 2022.

History · 11 fiscal years

Net assets by fiscal year

Medpace Holdings net assets (shareholders' equity), year by year

Medpace Holdings (MEDP) net assets (shareholders' equity) by fiscal year
Fiscal yearNet assetsChangeYear ended
2025$459.07M 44.4% down
2024$825.55M 47.7% up
2023$558.95M 44.7% up
2022$386.39M 59.5% down
2021$952.93M 18.3% up
2020$805.78M 10.9% up
2019$726.28M 21.3% up
2018$598.86M 17.6% up
2017$509.26M 16.6% down
2016$610.71M 47.7% up
2015$413.47M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value.

How to read it

Large buybacks and write-offs shrink it without the business getting worse, so a falling or negative figure needs the reason before a verdict.

Net assets at health care companies of similar size

Net assets of Medpace Holdings and comparable companies
CompanyNet assetsFiscal year
Alnylam Pharmaceuticals ALNY$789.18M2025
Zimmer Biomet Holdings ZBH$12.70B2025
Medpace Holdings MEDP$459.07M2025
Revvity RVTY$7.25B2025
Exelixis EXEL$2.16B2025
Charles River Laboratories International CRL$3.16B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on MEDP

Medpace Holdings, figure by figure

Medpace Holdings (MEDP) overview: price, valuation and scorecardAll health care companies by market value

Medpace Holdings net assets (shareholders' equity): questions and answers

What are Medpace Holdings's net assets?

Medpace Holdings (MEDP) had net assets of $459.07M at the end of fiscal 2025 (December 31, 2025). That is 44.4% lower than the $825.55M of fiscal 2024.

What is the growth rate of Medpace Holdings's net assets?

Over the five fiscal years to 2025 net assets shrank at a compound 10.6% a year; over ten years the rate was 1.1% a year.

What are the highest and lowest net assets figures on record for Medpace Holdings?

Across the 11 fiscal years on record (2015–2025), the highest was $952.93M in fiscal 2021 and the lowest $386.39M in fiscal 2022.

How is Medpace Holdings's net assets calculated?

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value. For Medpace Holdings it is on record here for 11 fiscal years, 2015 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Medpace Holdings (MEDP) net assets (shareholders' equity)”, data as of 19 November 2026. https://funkfolio.com/stock/MEDP/net-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.